FDA Approval Brightens Outlook for Thyroid Eye Disease Patients
After years without treatment options, people living with thyroid eye disease got a surprise from the FDA this week. Well before its anticipated March decision, the agency approved a first-of-its-kind medicine to treat the autoimmune disease. The drug, teprotumumab, is administered by infusion. Wiley Chambers, MD, of the FDA’s Center for Drug Evaluation and Research called the approval an “important milestone” for thyroid